ITM2B antibody (N-Term)
Quick Overview for ITM2B antibody (N-Term) (ABIN113331)
Target
See all ITM2B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purification
- Affinity chromatography.
-
Immunogen
- Peptide coupled to carrier protein. Amino terminal sequence of BRI protein (ITM2B)
-
-
-
-
Application Notes
-
Suitable for Western blot and not recommended for Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline, pH 7.2 with 0.09 % sodium azide as preservative.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 2-8 °C for one month or (following reconstitution in aliquots) at -20 °C for longer.
-
-
- ITM2B (Integral Membrane Protein 2B (ITM2B))
-
Alternative Name
- ITM2B
-
Background
- This antibody has been developed against the amino terminal sequence of BRI protein (ITM2B), a type-II single spanning transmembrane protein found in brain and other tissues. Mutation of the BRI gene with concomitant elongation of the carboxy terminus and its cleavage by the protease furin has been shown to lead to deposition of a protein fragment that may be involved in the pathogenesis of familial British dementia.Synonyms: BRI, BRI2, ITM2B, Integral membrane protein 2B, Transmembrane protein BRI
-
Gene ID
- 9445
-
NCBI Accession
- NP_068839
-
UniProt
- Q9Y287
Target
-